Signaling lymphocyte activation molecule family 7 (SLAMF7, also known as CS-1, CD319, and CRACC) is a receptor of the CD2 family that is overexpressed on myeloma cells, subsets of natural killer (NK) cells, macrophages, and T cells [3–5]. Here, SLAMF7 is linked to plasma cell myeloma.